Expanding Discussion on Medicare’s Long-Term Sustainability
TL/DR –
The Medicare Rights Center has launched a three-part series exploring the sustainability of Medicare, highlighting factors such as misaligned incentives, systemic inefficiencies, and complex financing structures that increase costs and complicate choices for beneficiaries. The series discusses the history and structure of Medicare funding, explaining how Parts A, B, and D are financed and how spending trends are shifting. The series calls for further reforms, including reducing Medicare Advantage overpayment, establishing provider site neutrality, and further lowering prescription drug costs, in order to enhance the sustainability, affordability, and solvency of Medicare.
Medicare Policy Inefficiencies and Complexities
Systemic inefficiencies, misaligned incentives, and increasing complexity in the Medicare policy landscape inflate costs and hinder beneficiaries’ ability to make informed decisions. A new three-part series by the Medicare Rights Center investigates issues threatening Medicare’s fiscal longevity, such as misunderstood financing structures, payment disparities, and the rapid expansion of Medicare Advantage plans.
Part 1: Understanding Medicare Financing
The first part of the series delves into Medicare’s financial structure, tracing its evolution from 1965 to the present. This broad historical overview shifts the policy dialogue from Part A solvency to overall sustainability.
The Evolution of Medicare Funding
Original Medicare’s three segments have distinct funding mechanisms. Part A is mostly funded through payroll taxes, making it susceptible to economic changes. Part B and Part D, responsible for most Medicare spending, are financed through a blend of general revenues and beneficiary premiums, ensuring stability in economic downturns.
Since its 1965 inception, Medicare’s financing structure has undergone multiple revisions to address fluctuations in economic conditions and Medicare’s specific requirements. As Supplementary Medical Insurance (SMI) spending increases, policy reforms must focus on Parts B and D. The Inflation Reduction Act (IRA) of 2022, which aims to reduce drug prices through negotiations, inflation rebates, and a Part D overhaul, is a step in the right direction.
Future Medicare Reforms
Additional reforms are necessary to enhance the SMI Trust Fund’s cost-effectiveness. Priorities include eliminating Medicare Advantage overpayment, promoting provider site neutrality, and further decreasing prescription drug costs. These measures can ensure a more sustainable Medicare program.
This policy series aims to encourage discussions on a sustainable future for Medicaid and Medicare, focusing on improving Medicare to ensure its long-term sustainability and affordability. Explore Part 1 on Medicare Financing from the Medicare Sustainability policy series.
Explore the Infographic
Medicare sustainability financing infographic
—
Read More US Economic News